Margaret K. King, Ph.D.
Affiliations: | 2014 | Psychology | University of Alabama, Birmingham, Birmingham, AL, United States |
Area:
Neuroscience BiologyGoogle:
"Margaret King"Parents
Sign in to add mentor| Richard S. Jope | grad student | 2014 | UAB | |
| (Contribution of hyperactive glycogen synthase kinase-3 (gsk3) to impaired neurogenesis and cognition in mice.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pardo M, King MK, Perez-Costas E, et al. (2015) Impairments in cognition and neural precursor cell proliferation in mice expressing constitutively active glycogen synthase kinase-3. Frontiers in Behavioral Neuroscience. 9: 55 |
| Franklin AV, King MK, Palomo V, et al. (2014) Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice. Biological Psychiatry. 75: 198-206 |
| King MK, Pardo M, Cheng Y, et al. (2014) Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments. Pharmacology & Therapeutics. 141: 1-12 |
| King MK, Jope RS. (2013) Lithium treatment alleviates impaired cognition in a mouse model of fragile X syndrome. Genes, Brain, and Behavior. 12: 723-31 |
| Mines MA, Yuskaitis CJ, King MK, et al. (2010) GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism. Plos One. 5: e9706 |
| Yuskaitis CJ, Mines MA, King MK, et al. (2010) Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome. Biochemical Pharmacology. 79: 632-46 |